EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Facioscapulohumeral Muscular Dystrophy Rasch‐Built Overall Disability Scale ( FSHD ‐ RODS ): Longitudinal Assessment of a Disease‐Specific Patient Reported Outcome

Sjan Teeselink iD, Sanne C C Vincenten iD, Nicol C Voermans, Nens van Alfen, Baziel G M van Engelen, Karlien Mul iD

European Journal of Neurology · 2025-08 · 32 (8)

DOI: 10.1111/ene.70238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 09.08.2025. Verfasst von Sjan Teeselink und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Patient Reported Outcome Measures, Disability Evaluation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Prinses Beatrix Spierfonds, FSHD Stichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess changes in the facioscapulohumeral muscular dystrophy Rasch‐Built Overall Disability Scale (FSHD‐RODS) over 6.5 years in FSHD patients.

Methods

FSHD patients of 18 years or older were assessed at baseline (T1) and followed up at 5 years (T2) and 6.5 years (T3). The patient‐reported FSHD‐RODS and Sickness Impact Profile 68 (SIP68) questionnaires were evaluated, alongside the FSHD clinical severity score, FSHD clinical score and Motor Function Measure (MFM). Individual minimal clinically important differences (MCID‐SE) of the FSHD‐RODS were calculated to assess the clinical importance of the change over time. A subgroup analysis included patients eligible for current clinical trials.

Results

Sixty‐two patients were included, representing the full disease spectrum. The FSHD‐RODS and SIP68 questionnaire outcomes remained stable, whereas overall disease severity slightly increased (FSHD clinical severity score 6 to 6.5, p < 0.001) and MFM slightly decreased (94% to 91%, p < 0.001). FSHD‐RODS correlated strongly with SIP68, MFM and disease severity ( ρ ≥ 0.69). The clinical trial subgroup ( n = 33) showed similar results. Ten patients (16%), all with moderate–to‐severe baseline disease (FSHD clinical severity score ≥ 6), showed clinically important deterioration over 6.5 years.

Conclusions

FSHD progression is generally slow, with FSHD‐RODS only detecting meaningful decline in moderately to severely affected patients. The ability to compensate for muscle weakness may limit the sensitivity of patient‐reported outcomes like FSHD‐RODS in clinical trials. These findings highlight the need for alternative measures to capture disease progression and treatment effects in FSHD research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralPatient Reported Outcome MeasuresDisability EvaluationHumansMaleFemaleMiddle AgedAdultLongitudinal StudiesSeverity of Illness IndexAgedDisease ProgressionSurveys and Questionnaires

Stichwörter der Autor:innen

FSHD‐RODSfacioscapulohumeral muscular dystrophypatient reported outcome

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.

ORCID-Profile: Sjan Teeselink, Sanne C C Vincenten, Karlien Mul

Förderung

  • Prinses Beatrix Spierfonds
  • FSHD Stichting

Zitieren

APA

Teeselink, S., Vincenten, S. C. C., Voermans, N. C., van Alfen, N., van Engelen, B. G. M., & Mul, K. (2025). The Facioscapulohumeral Muscular Dystrophy Rasch‐Built Overall Disability Scale ( FSHD ‐ RODS ): Longitudinal Assessment of a Disease‐Specific Patient Reported Outcome. European Journal of Neurology, 32(8). https://doi.org/10.1111/ene.70238

Vancouver

Teeselink S, Vincenten SCC, Voermans NC, van Alfen N, van Engelen BGM, Mul K. The Facioscapulohumeral Muscular Dystrophy Rasch‐Built Overall Disability Scale ( FSHD ‐ RODS ): Longitudinal Assessment of a Disease‐Specific Patient Reported Outcome. European Journal of Neurology. 2025;32(8). doi:10.1111/ene.70238

BibTeX
@article{Teeselink2025,
  author = {Teeselink, Sjan and Vincenten, Sanne C C and Voermans, Nicol C and van Alfen, Nens and van Engelen, Baziel G M and Mul, Karlien},
  title = {The Facioscapulohumeral Muscular Dystrophy Rasch‐Built Overall Disability Scale ( FSHD ‐ RODS ): Longitudinal Assessment of a Disease‐Specific Patient Reported Outcome},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {8},
  doi = {10.1111/ene.70238}
}
Kostenlos starten →